While Healthcare Stocks took a hit on Tuesday, dropping 0.97%, there were several companies that proved to have plenty of life with Icagen, Inc. (NASDAQ: ICGN) earning the top grade as shares jumped 78.69% on the day to close at 2.18. The spike came following ICGN’s announcement that they, along with their development partner Pfizer, had selected a compound that will be developed as a pain treatment. As part of the announcement ICGN said they will receive a $1 million milestone payment from Pfizer related to the selection of the compound. Shares climbed as high as 2.63, a three-month high, and the stock pushed past the 50-day moving average of 1.54 but still trails the 200-day moving average of 3.87.
Following news that their wholly owned subsidiary APP Pharmaceuticals, Inc. had received FDA approval to market Topotecan for Injection, Fresenius Kabi Pharma Holding, Inc. (NASDAQ: APCVZ) saw shares climb 40.18% on Tuesday to close at 0.0478 on nearly 6x their average trading volume. Shares managed to pass the 50-day moving average of 0.04 yet still trail the 200-day moving average of 0.11.
Repros Therapeutics, Inc. (NASDAQ: RPRX), a development stage biopharmaceutical company focused on the development of oral small molecule drugs for the treatment of male and female reproductive disorders, saw shares climb 26.5% on the day to close at 1.48. Shares in the company dropped earlier this month after the FDA asked for a second mid-stage trial for its experimental testosterone drug, Androxal. Shares are currently trailing the 50-day moving average of 1.73 and 200-day moving average of 2.27.
Simcere Pharmaceutical Group (NYSE: SCR) managed to turn bad news into good on Tuesday as shares climbed 13.87% to close at 12.48; this despite the fact Jiangsu Yanshen, a company that SCR holds a 52.5% stake in, was hit with a fine by a Chinese court for selling inferior products. Trading volume was more than 4x its average as shares hit a high of 12.86, a new 52-week high, and they soared past the 50-day moving average of 9.77 and 200-day moving average of 8.95.
Bioanalytical Systems, Inc. (NASDAQ: BASI), a company that provides contract development services and research equipment to pharmaceutical, medical research, and biotechnology companies and institutions worldwide, pushed forward 12.36% on Tuesday to close at 1.00. The push moved shares past the 50-day moving average of 0.92 and 200-day moving average of 0.96.
